HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Switzerland’s Ricola Breathes Life Into UK Medicated Confectionery Market

Executive Summary

Swiss confectioner Ricola wants to capitalize on a gap in the UK medicated confectionery market with its new Soothe & Clear line. 

You may also be interested in...



Australia Looking Into In-Vitro Self-Test Deregulation

In-vitro self-tests for influenza and sexually transmitted diseases as well as direct-to-consumer genetic tests are on the agenda for deregulation in Australia. 

Industry Ignored In Dispute Over UK Retailer’s ‘Weight Management’ Claim

Despite being defended by four industry representative bodies, UK health food retailer Holland & Barrett has been rapped for its use of “weight management” as a product category on its consumer-facing website by the country's Advertising Standards Authority. 

Switzerland Provides Gateway Into Mainland Europe For BASF’s Hepacor

With the Swiss launch of its Non-Alcoholic Fatty Liver Disease supplement, BASF is looking to make inroads into continental Europe. 

Topics

UsernamePublicRestriction

Register

RS149471

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel